Revesz syndrome: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
[[File:Autosomal_dominant_-_en.svg| | {{SI}} | ||
{{Infobox medical condition | |||
| name = Revesz syndrome | |||
| image = [[File:Autosomal_dominant_-_en.svg|200px]] | |||
| caption = Revesz syndrome is inherited in an [[autosomal dominant]] pattern. | |||
| synonyms = | |||
| pronounce = | |||
| specialty = [[Medical genetics]] | |||
| symptoms = [[Bilateral exudative retinopathy]], [[bone marrow failure]], [[cerebellar hypoplasia]], [[sensorineural hearing loss]], [[intracranial calcifications]] | |||
| complications = | |||
| onset = | |||
| duration = | |||
| types = | |||
| causes = Mutations in the [[TERT]] gene | |||
| risks = | |||
| diagnosis = | |||
| differential = | |||
| prevention = | |||
| treatment = | |||
| medication = | |||
| prognosis = | |||
| frequency = | |||
}} | |||
'''Revesz syndrome''' is a rare genetic disorder characterized by a combination of [[retinal degeneration]], [[bone marrow failure]], and other systemic abnormalities. It is a severe variant of [[dyskeratosis congenita]], a condition that affects the [[telomeres]], which are the protective caps at the ends of chromosomes. | |||
== Clinical Features == | == Clinical Features == | ||
Individuals with Revesz syndrome typically present with a range of symptoms, including: | Individuals with Revesz syndrome typically present with a range of symptoms, including: | ||
| Line 9: | Line 31: | ||
* [[Developmental delay]] | * [[Developmental delay]] | ||
* [[Skin abnormalities]] such as [[hyperpigmentation]] and [[nail dystrophy]] | * [[Skin abnormalities]] such as [[hyperpigmentation]] and [[nail dystrophy]] | ||
== Genetics == | == Genetics == | ||
Revesz syndrome is caused by mutations in the [[TERT]] gene, which encodes the [[telomerase reverse transcriptase]] enzyme. This enzyme is crucial for maintaining the length of [[telomeres]]. Mutations in the TERT gene lead to critically short telomeres, which in turn cause the clinical manifestations of the syndrome. | Revesz syndrome is caused by mutations in the [[TERT]] gene, which encodes the [[telomerase reverse transcriptase]] enzyme. This enzyme is crucial for maintaining the length of [[telomeres]]. Mutations in the TERT gene lead to critically short telomeres, which in turn cause the clinical manifestations of the syndrome. | ||
== Diagnosis == | == Diagnosis == | ||
The diagnosis of Revesz syndrome is based on clinical findings and genetic testing. Key diagnostic criteria include: | The diagnosis of Revesz syndrome is based on clinical findings and genetic testing. Key diagnostic criteria include: | ||
| Line 18: | Line 38: | ||
* Evidence of [[bone marrow failure]] | * Evidence of [[bone marrow failure]] | ||
* Identification of mutations in the [[TERT]] gene through genetic testing | * Identification of mutations in the [[TERT]] gene through genetic testing | ||
== Management == | == Management == | ||
There is no cure for Revesz syndrome, and treatment is primarily supportive. Management strategies include: | There is no cure for Revesz syndrome, and treatment is primarily supportive. Management strategies include: | ||
| Line 24: | Line 43: | ||
* Supportive care for [[vision loss]] | * Supportive care for [[vision loss]] | ||
* Management of other systemic complications as they arise | * Management of other systemic complications as they arise | ||
== Prognosis == | == Prognosis == | ||
The prognosis for individuals with Revesz syndrome is generally poor due to the severe nature of the condition and the risk of life-threatening complications such as [[bone marrow failure]] and [[intracranial hemorrhage]]. | The prognosis for individuals with Revesz syndrome is generally poor due to the severe nature of the condition and the risk of life-threatening complications such as [[bone marrow failure]] and [[intracranial hemorrhage]]. | ||
== See Also == | == See Also == | ||
* [[Dyskeratosis congenita]] | * [[Dyskeratosis congenita]] | ||
| Line 33: | Line 50: | ||
* [[Bone marrow failure]] | * [[Bone marrow failure]] | ||
* [[Retinal degeneration]] | * [[Retinal degeneration]] | ||
== See also == | |||
== | |||
* [[Dyskeratosis congenita]] | * [[Dyskeratosis congenita]] | ||
* [[Telomerase]] | * [[Telomerase]] | ||
* [[Bone marrow]] | * [[Bone marrow]] | ||
* [[Retina]] | * [[Retina]] | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Ophthalmology]] | [[Category:Ophthalmology]] | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
{{Genetic-disorder-stub}} | {{Genetic-disorder-stub}} | ||
{{medicine-stub}} | {{medicine-stub}} | ||
Latest revision as of 15:53, 8 April 2025

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC
| Revesz syndrome | |
|---|---|
| Synonyms | |
| Pronounce | |
| Specialty | Medical genetics |
| Symptoms | Bilateral exudative retinopathy, bone marrow failure, cerebellar hypoplasia, sensorineural hearing loss, intracranial calcifications |
| Complications | |
| Onset | |
| Duration | |
| Types | |
| Causes | Mutations in the TERT gene |
| Risks | |
| Diagnosis | |
| Differential diagnosis | |
| Prevention | |
| Treatment | |
| Medication | |
| Prognosis | |
| Frequency | |
| Deaths | N/A |
Revesz syndrome is a rare genetic disorder characterized by a combination of retinal degeneration, bone marrow failure, and other systemic abnormalities. It is a severe variant of dyskeratosis congenita, a condition that affects the telomeres, which are the protective caps at the ends of chromosomes.
Clinical Features[edit]
Individuals with Revesz syndrome typically present with a range of symptoms, including:
- Retinal degeneration leading to vision loss
- Bone marrow failure resulting in pancytopenia
- Cerebral calcifications
- Intracranial hemorrhage
- Developmental delay
- Skin abnormalities such as hyperpigmentation and nail dystrophy
Genetics[edit]
Revesz syndrome is caused by mutations in the TERT gene, which encodes the telomerase reverse transcriptase enzyme. This enzyme is crucial for maintaining the length of telomeres. Mutations in the TERT gene lead to critically short telomeres, which in turn cause the clinical manifestations of the syndrome.
Diagnosis[edit]
The diagnosis of Revesz syndrome is based on clinical findings and genetic testing. Key diagnostic criteria include:
- Presence of retinal degeneration
- Evidence of bone marrow failure
- Identification of mutations in the TERT gene through genetic testing
Management[edit]
There is no cure for Revesz syndrome, and treatment is primarily supportive. Management strategies include:
- Regular monitoring and treatment of bone marrow failure with hematopoietic stem cell transplantation if necessary
- Supportive care for vision loss
- Management of other systemic complications as they arise
Prognosis[edit]
The prognosis for individuals with Revesz syndrome is generally poor due to the severe nature of the condition and the risk of life-threatening complications such as bone marrow failure and intracranial hemorrhage.
See Also[edit]
See also[edit]

This article is a genetic disorder stub. You can help WikiMD by expanding it!
